The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Journal club · continued

Journal club: the CagriSema phase 2 combination paper — a second dataset posts 31–60

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

L
LeitermanTL3Regular8 Jun 2025#31

Filing a mild objection to the consensus on CagriSema phase 2 combination paper. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.

6 likes 14mo
GE
g.ekstromTL29 Jun 2025#32
B
BBramleyTL3Regular10 Jun 2025#33

The arithmetic in post #31 is right; the assumption feeding it is the part to check.

The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.

That matches what I was told, which is not the same as knowing it.

0 likes 14mo
KO
k.okaforTL211 Jun 2025#34
m.restrepo, post #22: Quoting the sentence rather than paraphrasing it changes the discussion. Paraphrase is where a claim quietly becomes stronger than the paper made it. The answer changed when I changed how I was measuring, which was informative. Go to post

Answering the question post #33 raises rather than the one it answers.

Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.

1 like in reply to #22 14mo
JH
j.habermannTL3Regular11 Jun 2025#35

On CagriSema phase 2 combination paper, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.

3 likes 14mo
NS
ni.stanescuTL212 Jun 2025#36

Whatever the answer on CagriSema phase 2 combination paper turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.

10 likes 14mo
AR
ambient_reviewTL3Regular13 Jun 2025#37
ai.vukovic, post #19: The arithmetic in post #16 is right; the assumption feeding it is the part to check. What would change my mind on CagriSema phase 2 combination paper is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more. Go to post

That is a fair summary of where the discussion has got to.

30 likes in reply to #19 13mo
PO
pe.onwukaTL214 Jun 2025#38
m.ekstrom, post #28: An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second. I am not the right person to answer the follow-up to this. Go to post

TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.

0 likes in reply to #28 13mo
SP
s.poulsenTL315 Jun 2025#39
MA
mi.almeidaTL215 Jun 2025#40

Coming back to post #36, because the follow-up matters more than the original answer.

Quoting the sentence rather than paraphrasing it changes the discussion. Paraphrase is where a claim quietly becomes stronger than the paper made it.

That is where I would start, not where I would stop.

6 likes 13mo
BN
bench_notesTL4 Moderator16 Jun 2025#41

Where I part company with post #38, and it is a narrow parting.

Two claims get bundled together under CagriSema phase 2 combination paper and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not.

Almost every disagreement in threads like this one dissolves once you say which of the two you are making.

3 likes 13mo
VB
v.baptistaTL217 Jun 2025#42

Post #41 is the version of this I will quote in future. One addition.

The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.

0 likes 13mo
PW
PharmNotes_WhitfieldTL4Pharmacist18 Jun 2025#43
pe.onwuka, post #38: TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it. Go to post

The summary that goes to the digest should say what the paper establishes, what it does not, and one thing the group could not settle. Three paragraphs, no more.

The literature is thinner on this than the confidence in the thread implies.

32 likes in reply to #38 13mo
SC
s.cabreraTL218 Jun 2025 · edited#44

I changed my mind about CagriSema phase 2 combination paper after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it happens.

16 likes 13mo
BA
b.aaltoTL219 Jun 2025#45

Post #41 put the caveat in the right place and I want to underline it.

CagriSema phase 2 combination paper has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.

6 likes 13mo
EL
e.lehtinenTL220 Jun 2025#46
system_suitability, post #16: Everything in post #14 holds. The case it does not cover is the one I have. I disagree with the framing of CagriSema phase 2 combination paper above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The reasoning depends on an assumption that is doing a lot of work and… Go to post

Nothing to add on the substance. Thank you for taking the question at face value.

1 like in reply to #16 13mo
FV
f.villalobosTL221 Jun 2025#47

Somebody should be asked to argue the paper's case even if nobody in the room believes it. Sessions where everyone agrees produce a summary nobody can use.

Flagging that the sources on this are thinner than the confidence in the thread suggests.

0 likes 13mo
TP
t.pereiraTL221 Jun 2025#48

Sessions run better when the paper is circulated with three specific questions attached. Open-ended reading produces an open-ended discussion.

23 likes 13mo
JW
journalclub_wrenTL3Regular22 Jun 2025#49

Bringing the previous paper on the same question makes the session much better and doubles the preparation. Worth doing every third session rather than every one.

The strength of my opinion here exceeds the strength of my evidence.

0 likes 13mo
EH
e.halonenTL223 Jun 2025#50
m.restrepo, post #22: Quoting the sentence rather than paraphrasing it changes the discussion. Paraphrase is where a claim quietly becomes stronger than the paper made it. The answer changed when I changed how I was measuring, which was informative. Go to post

Suggest the next paper at the end of the session rather than by message afterwards. The room has just worked out what it wants to know next.

If that is already documented somewhere, ignore me and link it.

33 likes in reply to #22 13mo
IO
i.oseiTL223 Jun 2025#51
f.villalobos, post #47: Somebody should be asked to argue the paper's case even if nobody in the room believes it. Sessions where everyone agrees produce a summary nobody can use. Flagging that the sources on this are thinner than the confidence in the thread suggests. Go to post

Building on post #48 rather than restating it.

An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second.

0 likes in reply to #47 13mo
CD
cohort_driftTL324 Jun 2025#52
SO
s.oyelaranTL225 Jun 2025#53

Acknowledging rather than arguing. The reasoning holds as far as I can follow it.

12 likes 13mo
O
OTeixeiraTL3Regular26 Jun 2025#54
pe.onwuka, post #38: TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it. Go to post

Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then limitations. That order makes critique coherent.

Adding a source would improve this post and I do not have one to hand.

26 likes in reply to #38 13mo
SB
s.beaulieuTL226 Jun 2025#55

Taking post #54 at face value and following it one step further.

The summary that goes to the digest should say what the paper establishes, what it does not, and one thing the group could not settle. Three paragraphs, no more.

This is the sort of thing that ought to be settled and apparently is not.

1 like 13mo
J
JFitzgibbonTL2Member27 Jun 2025 · edited#56

Post #54 and I disagree about the size of the effect, not about the direction.

Bringing the previous paper on the same question makes the session much better and doubles the preparation. Worth doing every third session rather than every one.

7 likes 13mo
TV
to.vargaTL228 Jun 2025#57

Practical answer on CagriSema phase 2 combination paper, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated explanation is needed. It usually is not.

18 likes 13mo
GH
g.haalandTL3Regular28 Jun 2025#58
j.habermann, post #35: On CagriSema phase 2 combination paper, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one. Go to post

Genuine question rather than a rhetorical one: has anyone here actually observed CagriSema phase 2 combination paper, as opposed to read about it? The thread is long and I cannot tell.

0 likes in reply to #35 13mo
AS
a.sorensenTL229 Jun 2025#59

Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything that follows.

Second-hand, so weight it accordingly.

0 likes 13mo
SD
s.duarteTL230 Jun 2025#60

Worth separating two things that post #58 runs together.

The reason CagriSema phase 2 combination paper keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.

0 likes 13mo